A cohort study on myasthenia gravis patients in China

Neurological Sciences

Volumn 34, Issue 10, 2013, Pages 1759-1764

  Wang, Wei ^a,b   Chen, Yu Ping ^b   Wang, Zhong Kui ^b   Wei, Dong Ning ^b   Yin, Ling ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b 309TH HOSPITAL OF PLA   (China)

Author keywords

Adult onset; China; Myasthenia gravis; Neostigmine test; Repetitive nerve stimulation (RNS)

Indexed keywords

ACETYLCHOLINESTERASE; NEOSTIGMINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREATHING MUSCLE; CHILD; CHINA; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; FACIAL NERVE; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NERVE STIMULATION; ONSET AGE; PRESCHOOL CHILD; PREVALENCE; REPETITIVE NERVE STIMULATION; SCHOOL CHILD; SEX RATIO; THYMOMA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHINA; CHOLINESTERASE INHIBITORS; COHORT STUDIES; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEOSTIGMINE; SEVERITY OF ILLNESS INDEX; THYMUS GLAND; YOUNG ADULT;

EID: 84886402473     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1329-5     Document Type: Article

References (21)

1. Chiu H-C, Vincent A, Newsom-Davis J, Hsieh KH, Hung T (1987) Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians. Neurology 37:1854-1857
2. Fukuyama Y, Hirayama Y, Osawa M (1981) Epidemiological and clinical features of childhood myasthenia gravis in Japan. In: Satyoshi E (ed) Myasthenia gravis - pathogenesis and treatment. University of Tokyo Press, Tokyo, pp 19-27
3. Xu J, Yang M, Li B et al (1999) Myasthenia gravis: clinical study in 2,385 patients. Chin J Neurol 32:347-350
4. Zhang X, Yang M, Xu J, Zhang M, Lang B, Wang W, Vincent A (2007) Clinical and serological study of myasthenia gravis in HuBei Province, China. J Neurol Neurosurg Psychiatry 78:386-390
5. Liu W, Men L, He X et al (2006) Clinical Analysis on 1,520 Patients with Myasthenia Gravis in Southern China. Chin J Neuroimmunol Neurol 13:326-330
6. Robertson NP, Deans J, Compston DA (1998) Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry 65:492-496
7. Beekman R, Kuks JB, Oosterhuis HJ (1997) Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol 244:112-118
8. Keesey JC (2004) Clinical evaluation and management of myasthenia gravis. Muscle Nerve 29:484-505
9. Wolfe GI, Barohn RJ (2009) Myasthenia gravis: classification and outcome measurements. In: Kaminski HJ (ed) Myasthenia gravis and related disorders, 2nd edn. Humana Press, New York, pp 293-302
10. Costa J, Evangelista T, Conceicao I, de Carvalho M (2004) Repetitive nerve stimulation in myasthenia gravis-relative sensitivity of different muscles. Clin Neurophysiol 115:2776-2782
11. Hasserjian RP, Strobel P, Marx A (2005) Pathology of thymic tumors. Semin Thorac Cardiovasc Surg 17:2-11
12. Sanders DB, Howard JF Jr (2008) Disorders of neuromuscular transmission. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J (eds) Bradley: neurology in clinical practice. 5th edn. Philadelphia, Pa, Butterworth-Heinemann Elsevier, chap 82
13. Carr AS, Cardwell CR, McCarron PO, McConville J (2010) A systematic review of population based epidemiological studies in Myasthenia. BMC Neurol 10:46-54
14. Aragonès JM, Bolíbar I, Bonfill X, Bufill E, Mummany A, Alonso F, Illa I (2003) Myasthenia gravis a higher than expected incidence in the elderly. Neurology 60:1024-1026
15. Mantegazza R, Baggi F, Antozzi C, Confalonieri P, Morandi L, Bernasconi P, Andreetta F, Simoncini O, Campanella A, Beghi E, Cornelio F (2003) Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann NY Acad Sci 998:413-423
16. Ashraf VV, Taly AB, Veerendarkumar M, Rao S (2006) Myasthenia gravis in children: a longitudinal study. Acta Neurol Scand 114:119-123
17. Kyriallis K, Hristova AH, Middleton LT (1995) What is the real epidemiology of myasthenia gravis? (abstract) Neurology 45(Suppl 4):PA351
18. Kawaguchi N, Kuwabara S, Nemoto Y, Fukutake T, Satomura Y, Arimura K, Osame M, Hattori T (2004) Study Group for Myasthenia Gravis in Japan: treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000. J Neurol Sci 224:43-47
19. Chen WH, Chiu HC, Hseih RP (1993) Association of HLA-Bw46DR9 combination with juvenile myasthenia gravis in Chinese. J Neurol Neurosurg Psychiatry 56:382-385
20. Chan KH, Cheung RTF, Mak W, Ho SL (2007) Nonthymoma early-onset and late-onset-generalized myasthenia gravis - A retrospective hospital-based study. Clin Neurol Neurosurg 109:686-691
21. Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8:475-490